Zoledronate Plus Standard Therapy Compared With Placebo Plus Standard Therapy to Prevent Bone Metastases in Patients With Recurrent Prostate Cancer That Has No Symptoms
Clinical trial NCT00005073 · TERMINATED
Trial details
- NCT number
- NCT00005073
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1999-09-01
- Primary completion
- 2003-03-01
- Enrollment
- 544
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.